COPD Flashcards
** disorder **: Destruction of alveoli and elastin fibres in the lung. May be caused by proteases released during the inflammatory response. Causes respiratory failure. Destruction of alveoli impairs gas transfer
Empyhsema
** Disorder **
* Attacks of winter morning cough
* Progresses to chronic cough with intermittent exacerbations
* Often initiated by an upper respiratory
infection
Bronchitis
main aim in COPD treatment
to reduce the progression of the disease, however does not supress inflammation or prevent the development of Emphysema
1st step in management of COPD
1) Smoking cessation –>Slows the progress of COPD
2) Immunizations –> Superimposed infections are potentially lethal
Drugs used in the treatment of COPD
1) Bronchodilators - β2 Adrenoreceptor agonists
2) Muscarininc receptor anatgonsits
3) Corticosetroids (CS)
short-acting drugs used in the tx of COPD
Short-acting drugs
1) Short-acting anti-muscarinic antagonists (SAMA):
Ipratropium
2) Short-acting beta agonists (SABA): salbutamol
Long-acting drugs used in the tx of COPD
Long-acting drugs
1) Long-acting anti-muscarinic antagonists (LAMA) :
Tiotropium
2) Long-acting beta agonists (LABA): salmeterol or
formoterol (LABA)
Muscarinic receptor antagonists used in the tx of COPD?
1) Ipratropium (Short-Acting Muscarinic Antagonist-SAMA)
2) Tiotropium (Long-Acting Muscarinic Antagonist-LAMA)
Adm of Ipratropim
- Inhalational
- Maximum effect: approximately 30 min after inhalation
- Persists for 3–5 h
Max effect of Ipratropium starts approx. —– after inhalation
30 min
Duration of Action of Ipratropium
3-5 hrs
Adm of Tiotropium
Inhalation
Longer-acting (t1/2=35 hours)
More potent than ipratropium
Which is more potent Ipratropium or Tiotropium?
Tiotropium
Duration of action of Tiotropium
Longer-acting (t1/2=35 hours)
AE of Muscarinic receptor agonists
* Ipratropium, Tiotropium
1) Dry mouth
2) Dry eyes
3) Raised intraocular pressure and blurred vision
(Caution in glaucoma)
4) Metallic taste
5) Constipation
6) Tachycardia (Caution in CV disease)
7) Urinary retention (Caution)
8) Cough/hoarse voice
Contraindications of Muscarinic receptor agonists
1) Glaucoma (raised intraocular pressure and blurred vission)
2) CV disease (Tachycardia)
3) Urinary retention
CU of Tiotropium
1) LAMA added w/ LABA when control insufficient
2) COPD
CU of Ipratropium
1) In Acute sever asthma, SAMA added w/ SABA which aguments (increases) bronchodilation of SABA
2) COPD
treatment approach to reduce inflammation in COPD
ICS (inhaled corticosteroids)
- note: oral corticosteroids should not be given to patients with stable COPD
MoA of inhaled corticosteroids in the management of COPD
1) Aim is to temper inflammation about COPD (tx not monotherpay)
2) Decrease frequency of exacerbation and improve quality of life
* not as effective in asthma
CU of Theophylline in COPD
tx of asthma and COPD esp in patients who tend to reatins CO2
not recommended due to its uncertain benefits!!!
What can you to give patients w/ sever COPD and Hypoxaemia?
Long-term O2 therapy (Adm at home)
Tx approach for Acute COPD exacerbation
1) Inhaled O2
2) Broad-spectrum abx if there is evidence of infection
3) Inhaled bronchodilators for symptomatic
improvement (SABA)
4) Oral prednisolone (CS)
Anti-Histamine 1st generation examples
diphenhydramine,
promethazine,
chlorpheniramine,
meclizine,
dimenhydrinate,
hydroxyzine